Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and... see more

TSXV:THRM - Post Discussion

Therma Bright Inc > Rapid Antigen Tests
View:
Post by Smokey1958 on Apr 10, 2021 8:29am

Rapid Antigen Tests

Rapid Antigen tests approved for use in Brazil (Anvisa) up to this date require a blood or nasopharyngeal sample and thus must be carried out in a lab setting and/or by a medical professional (expensive). The most recent device was approved in January so no new approval(s) in over 2 months. 

No new device approved by HC since February and nothing new on the list for companies applying for review in months. There is a very strong sense that kids in Ontario may not be going back to school after their "March Break" this week. A covid test to combat these measures was needed "yesterday".

Unfortunately cases are climbing in almost every corner of the planet and yet NO Rapid Antigen Test seems to have met the expectation, demand and absolute need for mass testing ....and as such very few governments have embraced it. In spite of opinions to the contrary AcuVid appears to be the only test device with any sign of promise.

While it would be a great day for shareholders to see positive results from Brazil and a quick turn around when making their application to HC ....the more important reason is fast becoming because the WORLD needs to find a way to stem the tide. Add to that, the rate of vaccinations in the developing world is abysmal ....and there is no sign of that changing any time soon.

HOPEfully the results from Brazil will come out early next week.

Be safe and have a great weekend!!!

Comment by baggerx99 on Apr 10, 2021 11:02am
Toronto, Ontario--(Newsfile Corp. - March 23, 2021) -  Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTC Pink: DTMXF) (the "Company" or "Datametrex") is pleased to announce that Heath Canada ("HC") has approved the PCL Inc.'s ("PCL") COVID19 AG Rapid test kit ("PCL Antigen"), an antigen point-of-care rapid test device under the ...more  
Comment by stockmonster6 on Apr 10, 2021 12:03pm
That news is wrong and has been adjusted. I follow v.dm. this news was 24 march. It also says they are approved to SELL this test. This test is a nasal swab.
Comment by Whydunnit on Apr 10, 2021 1:31pm
THRM could make a dent in global covid if it starts making 25 million units a month but what the world needs is 500 million a week, if not more.  I really hope if THRM clears all hurdles to commercialization that they find multiple partners around the world who can churn units out at massive numbers.  I say that not even for the revenue it would generate but because it would help beat ...more  
Comment by TheeRook on Apr 10, 2021 11:52pm
 The FDA did just that when they approved the The Tiger Tech COVID Plus Monitor is intended for use by trained personnel to help prevent exposure to and spread of SARS-CoV-2, the virus that causes COVID-19.  “The FDA is committed to continuing to support innovative methods to fight the COVID-19 pandemic through new screening tools,” said Jeff Shuren, M.D., J.D., director of FDA’s ...more  
Comment by Whydunnit on Apr 11, 2021 1:41am
Any idea what kind of sensitivity/specificity numbers it has? The tech I see as a future option is a breathalyzer unit a couple of groups are working on, results in a minute or two, but last I heard they were working on getting the numbers up to a more reliable level.  Still need a plastic mouthpiece for each person but maybe they can be sterilized to prevent garbage mountains.
Comment by TheeRook on Apr 11, 2021 2:28am
The clinical performance of the Tiger Tech COVID Plus Monitor was studied in hospital and school settings. The hospital study, which was considered a validation study, enrolled 467 asymptomatic individuals, including 69 confirmed positive cases, and demonstrated that the Tiger Tech COVID Plus Monitor had a positive percent agreement (proportion of the COVID-19 positive individuals identified ...more  
Comment by Whydunnit on Apr 11, 2021 3:23am
Thanks.  Pretty good numbers.
Comment by Smokey1958 on Apr 11, 2021 4:46pm
Very interesting development, TheeRock! Based on what I am reading in regards to the difference between approval and authorization, this device was authorized not approved. But that's a moot point because this is a device that would pair up well with AcuVid. As it can't be used to diagnose covid and as a positive result could be something other than covid ....having a secondary device like ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities